Actavis Plans To Adopt "Allergan" Corporate Name - Quick Facts

(RTTNews) - Actavis plc (ACT) announced that it will adopt a new corporate name - Allergan - following the anticipated successful completion of the acquisition of Allergan, Inc.

The company said that it plans to use the Allergan name as its corporate name and for its global branded pharmaceutical portfolio, and will retain the Actavis name for select geographic regions and product portfolios.

The change in corporate name would be subject to approval by Actavis' shareholders at its Annual General Meeting later this year.

Actavis noted that it will ask shareholders to approve its intention to adopt the Allergan name at its Annual General Meeting of Shareholders later this year. Pending shareholder approval, and formal adoption of the new corporate naming structure, Actavis will continue to operate under its current name and trade on the New York Stock Exchange under its present symbol - ACT.